Not Cleared Direct

DEN230027 - NaviCam ProScan (FDA 510(k) Clearance)

Dec 2023
Decision
242d
Days
Class 2
Risk

DEN230027 is an FDA 510(k) submission for the NaviCam ProScan. This device is classified as a Gastrointestinal Capsule Endoscopy Analysis Software Device (Class II - Special Controls, product code QZF).

Submitted by Ankon Technologies Co., Ltd. (Wuhan, CN). The FDA issued a Not Cleared (DENG) decision on December 12, 2023.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.1540. A Gastrointestinal Capsule Endoscopy Analysis Software Device Is Used To Analyze Pre-recorded Capsule Endoscopy Videos Of The Gastrointestinal Tract That Are Suspected Of Containing Lesions. This Device Uses Software Algorithms To Identify Images And Areas Of Interest As Outputs To Aid The Clinician In Analyzing Suspected Lesions, For Clinician Review Of Device Outputs. The Device May Contain Hardware To Support Interfacing With A Capsule Imaging System..

Submission Details

510(k) Number DEN230027 FDA.gov
FDA Decision Not Cleared Not Substantially Equivalent (DENG)
Date Received April 14, 2023
Decision Date December 12, 2023
Days to Decision 242 days
Submission Type Direct
Review Panel Gastroenterology & Urology (GU)
Summary -

Device Classification

Product Code QZF - Gastrointestinal Capsule Endoscopy Analysis Software Device
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.1540
Definition A Gastrointestinal Capsule Endoscopy Analysis Software Device Is Used To Analyze Pre-recorded Capsule Endoscopy Videos Of The Gastrointestinal Tract That Are Suspected Of Containing Lesions. This Device Uses Software Algorithms To Identify Images And Areas Of Interest As Outputs To Aid The Clinician In Analyzing Suspected Lesions, For Clinician Review Of Device Outputs. The Device May Contain Hardware To Support Interfacing With A Capsule Imaging System.